NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Mar 10 2023

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-10-2023-4

Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases